Cargando…

Role of Fibroblast Growth Factor 21 in Biology of Glucagon

Detalles Bibliográficos
Autores principales:	Berglund, Eric D., Unger, Roger H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636638/ https://www.ncbi.nlm.nih.gov/pubmed/23613555 http://dx.doi.org/10.2337/db12-1840

Ejemplares similares

Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
por: Habegger, Kirk M., et al.
Publicado: (2013)

Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists
por: Pearson, Mackenzie J., et al.
Publicado: (2016)

Does GLP-1 suppress hepatocyte glucose production directly, via fibroblast growth factor 21?
por: Liu, Jun-Li, et al.
Publicado: (2019)

Glucagon as a Critical Factor in the Pathology of Diabetes
por: Edgerton, Dale S., et al.
Publicado: (2011)

Regulation and Potential Biological Role of Fibroblast Growth Factor 21 in Chronic Kidney Disease
por: Zhou, Xue, et al.
Publicado: (2021)

The starvation hormone, fibroblast growth factor-21, extends lifespan in mice
por: Zhang, Yuan, et al.
Publicado: (2012)

Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output
por: Liu, Junling, et al.
Publicado: (2019)

Emerging roles of fibroblast growth factor 21 in critical disease
por: Yan, Fang, et al.
Publicado: (2022)

Liver-brain axis with alcohol: Role of fibroblast growth factor 21 (FGF21)
por: Zhang, Ke, et al.
Publicado: (2023)

Regulating Glucagon Secretion: Somatostatin in the Spotlight
por: Rutter, Guy A.
Publicado: (2009)

Glucagon signaling in the heart: Activation or inhibition?()
por: Pocai, Alessandro
Publicado: (2014)

Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes
por: Son, Jang Won
Publicado: (2021)

Fibroblast growth factor 21 in heart failure
por: Tucker, William, et al.
Publicado: (2022)

Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

Fibroblast growth factor 21 and bone homeostasis
por: Tang, Yan, et al.
Publicado: (2023)

Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
por: Kwok, Kelvin H. M., et al.
Publicado: (2017)

Ketosis-Prone Atypical Diabetes: Glucagon Is There, Too
por: Lefèbvre, Pierre
Publicado: (2013)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
por: Kalra, Sanjay, et al.
Publicado: (2016)

Is ghrelin a glucagon‐like peptide‐1 secretagogue?
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Adapting to the Cold: A Role for Endogenous Fibroblast Growth Factor 21 in Thermoregulation?
por: Klein Hazebroek, Marlou, et al.
Publicado: (2020)

Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
por: Kimura, Tomohiko, et al.
Publicado: (2022)

Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
por: Kim, Jin Hee, et al.
Publicado: (2021)

Transcriptional Regulation of Fibroblast Growth Factor 21 Expression
por: Bae, Kwi-Hyun, et al.
Publicado: (2014)

Fibroblast growth factor 21 and fructose dynamics in humans
por: Migdal, A., et al.
Publicado: (2018)

Fibroblast growth factor 21 and fructose dynamics in humans
Publicado: (2019)

Mechanism of fibroblast growth factor 21 in cardiac remodeling
por: Zhao, Zeyu, et al.
Publicado: (2023)

Taking Aim at Islet Hormones With GLP-1: Is Insulin or Glucagon the Better Target?
por: D'Alessio, David A.
Publicado: (2010)

The Welcome Resurgence of the α-Cell: A Pro Glucagon Commentary
por: Robertson, R. Paul
Publicado: (2010)

Glucagon Peptide Family and Adipose Tissue: Not that Intimate, just Acquaintances
por: Perez-Tilve, Diego
Publicado: (2020)

Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets
por: Le, Thao D.V., et al.
Publicado: (2023)

Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes
por: Araki, Eiichi, et al.
Publicado: (2022)

Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels
por: Cuevas-Ramos, Daniel, et al.
Publicado: (2012)

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
por: Fisher, ffolliott M., et al.
Publicado: (2010)

Fibroblast growth factor 21 has no direct role in regulating fertility in female mice
por: Singhal, Garima, et al.
Publicado: (2016)

Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues
por: Lin, Xiaolong, et al.
Publicado: (2017)

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
por: Xiao, Mengjie, et al.
Publicado: (2021)

Glucose Control of Glucagon Secretion: There Is More to It Than K(ATP) Channels
por: Gylfe, Erik
Publicado: (2013)

Glucagon‐like peptide‐1 receptor agonists and their effects on weight reduction
por: Shin, Shyi‐Jang
Publicado: (2012)

Regulation of glucagon‐like peptide‐1 sensitivity by gut microbiota dysbiosis
por: Yamane, Shunsuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9d766ghui2loe3of40p8rf71s2